|
?:authorAffiliation
|
-
[\'Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, CA 94158, USA.\', \'QBI, University of California, San Francisco, CA 94158, USA.\', \'Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.\', \'J. David Gladstone Institutes, San Francisco, CA 94158, USA.\', \'Medical Scientist Training Program, University of California, San Francisco, CA 94143, USA.\', \'Department of Microbiology and Immunology, University of California, San Francisco, CA 94143, USA.\', \'Biomedical Sciences Graduate Program, University of California, San Francisco, CA 94143, USA.\', \'Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, 75724, Paris, cedex 15, France.\', \'Institute for Clinical and Experimental Pharmacology and Toxicology I, University of Freiburg, 79104 Freiburg, Germany.\', \'Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.\', \'Aetion, Inc., New York, NY 10001, USA.\', \'QBI Coronavirus Research Group Structural Biology Consortium, University of California, San Francisco, CA 94158, USA.\', \'Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA.\', \'Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.\', \'Howard Hughes Medical Institute, San Francisco, CA 94158, USA.\', \'European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.\', \'Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.\', \'Beam Therapeutics, Cambridge, MA 02139, USA.\', \'Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94158, USA.\', \'Department of Biomedical Science, Centre for Membrane Interactions and Dynamics, University of Sheffield, Firth Court, Sheffield S10 2TN, UK.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.\', \'Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.\', \'MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, Scotland, UK.\', \'Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.\', \'Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.\', \'Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari \'ALDO MORO\', Via Orabona, 4 70125, Bari, Italy.\', \'Institute of Virology, Medical Center-University of Freiburg, 79104 Freiburg, Germany.\', \'Département de Virologie, CNRS UMR 3569, Institut Pasteur, Paris 75015, France.\', \'Department of Medicine, University of California, San Diego, CA 92093, USA.\', \'Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.\', \'MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.\', \'HealthVerity, Philadelphia, PA 19103, USA.\', \'Department of Neurology, University of California, San Francisco, CA 94143, USA.\', \'Synthego Corporation, Redwood City, CA 94063, USA.\', \'Department of Epidemiology & Biostatistics, University of California, San Francisco, CA 94158, USA.\', \'Chan-Zuckerberg Biohub, San Francisco, CA 94158, USA.\', \'Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94158, USA.\', \'Cardiovascular Research Institute, University of California, San Francisco, CA 94158, USA.\', \'The University of California, Berkeley-University of California, San Francisco Graduate Program in Bioengineering, University of California, San Francisco, CA 94158, USA.\', \'Department to Bioengineering, University of California, San Diego, CA 92093, USA.\', \'Department of Medicine, University of California, San Francisco, CA 94143, USA.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. nevan.krogan@ucsf.edu pbeltrao@ebi.ac.uk marco.vignuzzi@pasteur.fr cbasler@gsu.edu verba@msg.ucsf.edu oren.rosenberg@ucsf.edu a.peden@sheffield.ac.uk robert.grosse@pharmakol.uni-freiburg.de jeremy.rassen@aetion.com Adolfo.Garcia-Sastre@mssm.edu.\', \'Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.\', \'The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.\', \'Aetion, Inc., New York, NY 10001, USA. nevan.krogan@ucsf.edu pbeltrao@ebi.ac.uk marco.vignuzzi@pasteur.fr cbasler@gsu.edu verba@msg.ucsf.edu oren.rosenberg@ucsf.edu a.peden@sheffield.ac.uk robert.grosse@pharmakol.uni-freiburg.de jeremy.rassen@aetion.com Adolfo.Garcia-Sastre@mssm.edu.\', \'Institute for Clinical and Experimental Pharmacology and Toxicology I, University of Freiburg, 79104 Freiburg, Germany. nevan.krogan@ucsf.edu pbeltrao@ebi.ac.uk marco.vignuzzi@pasteur.fr cbasler@gsu.edu verba@msg.ucsf.edu oren.rosenberg@ucsf.edu a.peden@sheffield.ac.uk robert.grosse@pharmakol.uni-freiburg.de jeremy.rassen@aetion.com Adolfo.Garcia-Sastre@mssm.edu.\', \'Centre for Integrative Biological Signaling Studies (CIBSS), University of Freiburg, 79104 Freiburg, Germany.\', \'Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, CA 94158, USA. nevan.krogan@ucsf.edu pbeltrao@ebi.ac.uk marco.vignuzzi@pasteur.fr cbasler@gsu.edu verba@msg.ucsf.edu oren.rosenberg@ucsf.edu a.peden@sheffield.ac.uk robert.grosse@pharmakol.uni-freiburg.de jeremy.rassen@aetion.com Adolfo.Garcia-Sastre@mssm.edu.\', \'Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA. nevan.krogan@ucsf.edu pbeltrao@ebi.ac.uk marco.vignuzzi@pasteur.fr cbasler@gsu.edu verba@msg.ucsf.edu oren.rosenberg@ucsf.edu a.peden@sheffield.ac.uk robert.grosse@pharmakol.uni-freiburg.de jeremy.rassen@aetion.com Adolfo.Garcia-Sastre@mssm.edu.\', \'Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Institut Pasteur, 75724, Paris, cedex 15, France. nevan.krogan@ucsf.edu pbeltrao@ebi.ac.uk marco.vignuzzi@pasteur.fr cbasler@gsu.edu verba@msg.ucsf.edu oren.rosenberg@ucsf.edu a.peden@sheffield.ac.uk robert.grosse@pharmakol.uni-freiburg.de jeremy.rassen@aetion.com Adolfo.Garcia-Sastre@mssm.edu.\', \'Department of Biomedical Science, Centre for Membrane Interactions and Dynamics, University of Sheffield, Firth Court, Sheffield S10 2TN, UK. nevan.krogan@ucsf.edu pbeltrao@ebi.ac.uk marco.vignuzzi@pasteur.fr cbasler@gsu.edu verba@msg.ucsf.edu oren.rosenberg@ucsf.edu a.peden@sheffield.ac.uk robert.grosse@pharmakol.uni-freiburg.de jeremy.rassen@aetion.com Adolfo.Garcia-Sastre@mssm.edu.\', \'European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK. nevan.krogan@ucsf.edu pbeltrao@ebi.ac.uk marco.vignuzzi@pasteur.fr cbasler@gsu.edu verba@msg.ucsf.edu oren.rosenberg@ucsf.edu a.peden@sheffield.ac.uk robert.grosse@pharmakol.uni-freiburg.de jeremy.rassen@aetion.com Adolfo.Garcia-Sastre@mssm.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}